New! Sign up for our email newsletter on Substack.

Shocking the Spine Back to Life

Electrical Stimulation Shows Promise for Spinal Muscular Atrophy

Imagine a world where the relentless march of neurodegenerative disease could be slowed, not just with drugs, but with electricity. A new pilot study from the University of Pittsburgh suggests this might be possible, at least for some individuals with spinal muscular atrophy (SMA). The research, published in Nature Medicine, reveals that targeted electrical stimulation of the spinal cord can reawaken dormant motor neurons, leading to improvements in muscle strength, walking ability, and reduced fatigue. This isn’t just about managing symptoms; it’s about potentially reversing some of the underlying neural dysfunction.

SMA is a genetic disease that progressively robs people of their motor skills. It attacks motor neurons, the nerve cells that control muscle movement. While recent advances in gene therapy and medications offer some hope by slowing disease progression, they haven’t been able to fully reverse the damage. This leaves many patients with lingering weakness and fatigue. The Pittsburgh team aimed to address this unmet need by targeting a key feature of the disease: the reduced communication between sensory nerves and motor neurons.

“To counteract neurodegeneration, we need two things – stop neuron death and restore function of surviving neurons,” explained Marco Capogrosso, Ph.D., assistant professor of neurosurgery at Pitt and co-corresponding author of the study. Existing treatments primarily focus on preventing further neuron death. This new approach, however, aims to “reverse nerve cell dysfunction.”

The researchers theorized that by amplifying sensory input to the motor neurons, they could essentially “reawaken” these cells and improve communication between the nervous system and the muscles. They tested this idea in a small pilot trial involving three adults with milder forms of SMA (Type 3 or 4).

The study participants underwent a 29-day period where they received regular sessions of epidural spinal cord stimulation (SCS). This involved implanting electrodes near the spinal cord to deliver targeted electrical pulses to sensory nerve roots. The stimulation wasn’t constant; it was delivered during specific motor tasks, like walking.

The results were surprising. “Because SMA is a progressive disease, patients do not expect to get better as time goes on. But that is not what we saw in our study,” said Elvira Pirondini, Ph.D., assistant professor of physical medicine and rehabilitation at Pitt and co-corresponding author. “Over the four weeks of treatment, our study participants improved in several clinical outcomes with improvements in activities of daily living. For instance, toward the end of the study, one patient reported being able to walk from their home to the lab without becoming tired.”

All three participants saw improvements in the 6-Minute Walk Test, a measure of endurance and fatigue. They walked significantly farther after the intervention. These functional improvements were mirrored by changes at the cellular level. The researchers observed increased activity in the motor neurons, suggesting the stimulation was having the desired effect.

One of the most intriguing findings was that these improvements weren’t just present during stimulation; they persisted even when the device was turned off. This suggests that the stimulation might be triggering long-lasting changes in the nervous system. “Our results suggest that this neurostimulation approach could be broadly applied to treat other neurodegenerative diseases beyond SMA, such as ALS or Huntington’s disease, as long as appropriate cell targets are identified in the course of future research,” said Robert Friedlander, M.D., chair of neurosurgery at Pitt and co-director of the UPMC Neurological Institute.

The researchers were careful to compare their results to what might be expected from exercise alone. They analyzed data from a previous study that looked at the effects of exercise in SMA patients and found that the improvements seen with SCS were far greater than those seen with exercise alone. This strengthens the argument that the electrical stimulation is playing a critical role.

The study also delved into the mechanisms by which SCS might be working. They found that the stimulation seemed to be improving the communication between sensory nerves and motor neurons, which is thought to be disrupted in SMA. They also saw changes in the excitability of the motor neurons themselves, making them more responsive.

While the results are promising, the researchers emphasize that this is a small pilot study and more research is needed. They are planning larger clinical trials to confirm these findings and investigate the long-term effects of SCS in SMA. They also want to explore whether this approach could be beneficial for other neurodegenerative conditions.

This research represents a new way of thinking about treating neurodegenerative diseases. Instead of just trying to prevent further damage, it might be possible to actually repair some of the damage that’s already been done. If these findings hold up in larger studies, it could offer a new hope for people living with SMA and potentially other debilitating neurological conditions.

One of the study’s limitations, the authors note, is its small size. With only three participants, it’s difficult to generalize the findings to the broader SMA population. Future studies with larger and more diverse groups of patients will be essential to validate these initial results. Additionally, the mechanisms by which SCS exerts its therapeutic effects are not fully understood. More research is needed to unravel the complex interplay between electrical stimulation, neural circuits, and muscle function.

Despite these limitations, the study offers a compelling glimpse into the potential of neurostimulation to treat neurodegenerative diseases. It’s a reminder that the nervous system, while complex, is not immutable. With the right tools, it may be possible to nudge it back towards health and restore lost function. The future of neurodegenerative disease treatment may well involve a combination of approaches, including gene therapy, medication, and – perhaps surprisingly – electricity.


Did this article help you?

If you found this piece useful, please consider supporting our work with a small, one-time or monthly donation. Your contribution enables us to continue bringing you accurate, thought-provoking science and medical news that you can trust. Independent reporting takes time, effort, and resources, and your support makes it possible for us to keep exploring the stories that matter to you. Together, we can ensure that important discoveries and developments reach the people who need them most.